https://www.indianpharmapost.com/bayers-sevabertinib-granted-fda-priority-review-for-the-treatment-of-patients-with-her2-mutant-non-small-cell-lung-cancer-172162025-05-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/pimicotinib-demonstrates-best-in-class-potential-with-significant-efficacy-and-clinically-meaningful-improvements-in-patients-with-tenosynovial-giant-cell-tumor-172172025-05-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/usvs-united-for-bp-control-mission-takes-aim-at-indias-blood-pressure-epidemic-172182025-05-29T00:00:00+05:30always0.9https://www.indianpharmapost.com/zydus-receives-usfda-fast-track-designation-for-novel-oral-inhibitor-usnoflast-172192025-05-29T00:00:00+05:30always0.9